# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 121-130 of 500 results.
Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B
Status: Recruiting
Last Changed: Jan 23, 2020
First Received: Apr 05, 2019
Disease(s): Chronic Hepatitis B
Intervention(s): Placebo Oral Tablet, Nitazoxanide
Locations: National University Hospital, Singapore, Singapore
Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District
Status: Recruiting
Last Changed: Jul 09, 2020
First Received: Aug 28, 2019
Disease(s): Hepatitis B Virus, Health Care Associated Infection
Intervention(s): Engerix-B
Locations: Kalulushi district all facilities, Kalulushi, Copperbelt, Zambia
Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Aug 14, 2019
Disease(s): Liver Transplant; Complications, Hepatitis C
Locations: Yale School of Medicine, New Haven, Connecticut, United States
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy
Status: Recruiting
Last Changed: Nov 08, 2019
First Received: Nov 08, 2019
Disease(s): Chronic Hepatitis b
Intervention(s): TDF tablet, Entecavir Tablet, QL-007
Locations: Southern Hospital of Southern Medical University, Guangzhou, Guangdong, China
The first hospital of jilin university, Changchun, Jilin, China
Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response
Status: Recruiting
Last Changed: Oct 23, 2020
First Received: Oct 08, 2020
Disease(s): Hepatitis C Virus (HCV)
Locations: Infectious Clinical Hosp #1 /ID# 225063, Moscow, Russian Federation
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
Status: Recruiting
Last Changed: Nov 26, 2020
First Received: Nov 06, 2016
Disease(s): Hepatitis B, Chronic
Intervention(s): Placebo, RO7020531
Locations: Gastroenterology department, Second clinic of internal diseases, Sofia, Bulgaria
COMAC Medical; Clinical Research Unit for Phase I, Sofia, Bulgaria
Queen Mary Hospital, Hong Kong, Hong Kong
The Chinese University of Hong Kong, Shatin, Hong Kong
Azienda Ospedaliero Universitaria Di Modena Policlinico; U.O. Farmacia, Modena, Emilia-Romagna, Italy
... and 14 other locations.
Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients
Status: Not yet recruiting
Last Changed: Nov 23, 2018
First Received: Nov 07, 2018
Disease(s): Chronic Hepatitis b, Efficacy, Self
Intervention(s): Interferon Alfa 2a
Locations: Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Eliminate Hepatitis C/EC Partnership Evaluation Protocol
Status: Recruiting
Last Changed: Aug 20, 2019
First Received: Aug 20, 2019
Disease(s): Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic
Intervention(s): EC clinic support - whole of practice interventions delivery through nurse-led model
Locations: Burnet Institute, Melbourne, Victoria, Australia
Transplanting Hepatitis C Positive Thoracic Organs
Status: Recruiting
Last Changed: Feb 12, 2019
First Received: Mar 22, 2017
Disease(s): Hepatitis C, Awaiting Organ Transplant
Intervention(s): Sofosbuvir/velpatasvir, Monitoring
Locations: Brigham and Women's Hospital, Boston, Massachusetts, United States
A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection
Status: Recruiting
Last Changed: Aug 06, 2020
First Received: Jan 30, 2020
Disease(s): Hepatitis B, Chronic
Intervention(s): ATI-2173, ATI-2173 Placebo
Locations: Altasciences, Montréal, Quebec, Canada
Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit, Chisinau, Republic Of Moldova, Moldova, Republic of
Medical Center of Limited Liability Company "Harmoniya krasy" Department of Clinical Trials, Kyiv, Ukraine